Dyslipidemias are common and increase the risk of cardiovascular disease. The menopause transition is associated with an atherogenic lipid profile.
Published in Maturitas, EMAS has produced an evidence-based clinical guide evaluating the effects on the lipid profile both of menopausal hormone therapy and of non-estrogen-based treatments for menopausal symptoms.
Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.